Cefovecin sodium

Cefovecin sodium 구조식 이미지
카스 번호:
141195-77-9
상품명:
Cefovecin sodium
동의어(영문):
UK287;UK 287;D01681;C13142;074-02;UK-287;UK287,074-02;UK 287,074-02;UK-287,074-02;Cefovecin SodiuM
CBNumber:
CB91260675
분자식:
C17H18N5NaO6S2
포뮬러 무게:
0
MOL 파일:
141195-77-9.mol

Cefovecin sodium 속성

저장 조건
Hygroscopic, -20°C Freezer, Under inert atmosphere
InChIKey
QRIBXVGHDLFNNE-RUPIGQPYNA-M
SMILES
[Na+].N12[C@@]([H])([C@H](NC(/C(/C3=CSC(N)=N3)=N/OC)=O)C1=O)SCC([C@@H]1CCCO1)=C2C([O-])=O |&1:2,4,23,r|

안전

Cefovecin sodium C화학적 특성, 용도, 생산

개요

Cefovecin sodium is a semi-synthetic broad-spectrum antibacterial agent from the cephalosporin class of chemotherapeutic agents. Cefovecin is the non-proprietary designation for (6R,7R)-7- [[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[(2S)-tetrahydro-2-furanyl]-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, monosodium salt.
Cefovecin Sodium is an antibiotic of the cephalosporin class. It is used for the treatment of skin infections caused by Pasturella multocida in cats, and Staphylococcus intermedius/S. canis in dogs. Cefovecin Sodium is the first single-dose injectable antibiotic for dogs and cats.

용도

Sodium salt of Cefovecin, a cephalosporin antibiotic used in the treatment of skin conditions in dogs and cats.

Indications

Dogs
Cefovecin sodium is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Cats
Cefovecin sodium is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

부작용

In cats, the most common effects are vomiting, diarrhea, decreased appetite, lethargy, hyperactivity or “acting strange” and inappropriate urination.
In dogs, the most common adverse effects were lethargy, decreased appetite, vomiting, diarrhea, blood in feces, dehydration, and flatulence.

Safety

Dogs
CONVENIA administered to healthy four month old dogs at doses of 12 mg/kg (1.5 X), 36 mg/kg (4.5 X), and 60 mg/kg (7.5 X) every seven days by dorsoscapular subcutaneous injections was well-tolerated for a total of 5 doses. Vomiting and diarrhea were seen in all treatment groups, with the incidence of vomiting and the incidence and duration of diarrhea increasing in a dose-related manner. Injection site irritation and transient edema occurred with increasing frequency in a dose-related manner and with repeat injections. Two injection site reactions included a seroma over the shoulder and swelling lasting > 30 days. Dogs dosed at 36 mg/kg had a significant (p = 0.0088) increase in BUN (all means remained within the normal range) compared to the controls. One dog dosed at 60 mg/kg exhibited a glomerulopathy on histopathology, and one dog in this same group had minimal peliosis hepatis. At an exaggerated dose of 180 mg/kg (22.5X) in dogs, CONVENIA caused some injection site irritation, vocalization and edema. Edema resolved within 8-24 hours.
www.zoetisus.com

Cefovecin sodium 준비 용품 및 원자재

원자재

준비 용품


Cefovecin sodium 공급 업체

글로벌( 49)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Masteam Bio-tech Co., Ltd.
+86-15200345168 +86-15200345168
bruce.lei@masteam.com CHINA 153 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
ENBRIDGE PHARMTECH CO., LTD.
+8613812269233
tinayang@enbridgepharm.com China 303 58
Shanghai UCHEM Inc.
+862156762820 +86-13564624040
sales@myuchem.com China 6708 58
AFINE CHEMICALS LIMITED
0571-85134551 18958018566;
info@afinechem.com China 15377 58
Hainan Mike Biomedical Technology Co., Ltd
+86-15120707353 +86-18876637353
tunanmedicine@hotemail.com China 43 58
Wuhan Fortuna Chemical Co., Ltd
+86-027-59207850
info@fortunachem.com China 6006 58
Baoji Guokang Healthchem co.,ltd
+8615604608665 15604608665
dominicguo@gk-bio.com CHINA 9427 58
Alfa Chemistry
+1-5166625404
Info@alfa-chemistry.com United States 21317 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58

Copyright 2019 © ChemicalBook. All rights reserved